These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33037018)

  • 1. Noninvasive Detection of Urothelial Carcinoma by Cost-effective Low-coverage Whole-genome Sequencing from Urine-Exfoliated Cell DNA.
    Zeng S; Ying Y; Xing N; Wang B; Qian Z; Zhou Z; Zhang Z; Xu W; Wang H; Dai L; Gao L; Zhou T; Ji J; Xu C
    Clin Cancer Res; 2020 Nov; 26(21):5646-5654. PubMed ID: 33037018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
    Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
    Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Urine-Based Assay for Bladder Cancer Diagnosis: Multi-Institutional Validation Study.
    Davis N; Shtabsky A; Lew S; Rona R; Leibovitch I; Nativ O; Cohen M; Mor Y; Lindner U; Glickman Y; Matzkin H; Tsivian A; Gofrit O; Yossepovitch O
    Eur Urol Focus; 2018 Apr; 4(3):388-394. PubMed ID: 28753799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma.
    Veeramachaneni R; Nordberg ML; Shi R; Herrera GA; Turbat-Herrera EA
    Diagn Cytopathol; 2003 Jun; 28(6):301-7. PubMed ID: 12768634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary Molecular Pathology for Patients with Newly Diagnosed Urothelial Bladder Cancer.
    Zhang R; Zang J; Xie F; Zhang Y; Wang Y; Jing Y; Zhang Y; Chen Z; Shahatiaili A; Cai MC; Zhao Z; Du P; Jia S; Zhuang G; Chen H
    J Urol; 2021 Oct; 206(4):873-884. PubMed ID: 34061567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Numerical aberrations of chromosomes 11 and 17 detected by fish--fluorescence in situ hybridization combined with cytology in exfoliated cells from voided urine in patients with urothelial carcinoma of the bladder].
    Asali MG; Kaneti J; Manor E
    Harefuah; 2007 Dec; 146(12):914-9, 1000. PubMed ID: 18254439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of urinary nuclear matrix protein 22 (NMP22) as a diagnostic adjunct to urine cytology for monitoring of recurrent bladder cancer--institutional experience and review.
    Önal B; Han Ü; Yilmaz S; Köybasioglu F; Altuğ U
    Diagn Cytopathol; 2015 Apr; 43(4):307-14. PubMed ID: 25488052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary Exosomal and cell-free DNA Detects Somatic Mutation and Copy Number Alteration in Urothelial Carcinoma of Bladder.
    Lee DH; Yoon H; Park S; Kim JS; Ahn YH; Kwon K; Lee D; Kim KH
    Sci Rep; 2018 Oct; 8(1):14707. PubMed ID: 30279572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescent in situ hybridization as a predictor of relapse in urothelial carcinoma.
    García-Peláez B; Trias I; Román R; Pubill C; Banús JM; Puig X
    Actas Urol Esp; 2013; 37(7):395-400. PubMed ID: 23453297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation of Aurora kinase A gene copy number in urine sediments and bladder cancer detection.
    Park HS; Park WS; Bondaruk J; Tanaka N; Katayama H; Lee S; Spiess PE; Steinberg JR; Wang Z; Katz RL; Dinney C; Elias KJ; Lotan Y; Naeem RC; Baggerly K; Sen S; Grossman HB; Czerniak B
    J Natl Cancer Inst; 2008 Oct; 100(19):1401-11. PubMed ID: 18812553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UCseek: ultrasensitive early detection and recurrence monitoring of urothelial carcinoma by shallow-depth genome-wide bisulfite sequencing of urinary sediment DNA.
    Wang P; Shi Y; Zhang J; Shou J; Zhang M; Zou D; Liang Y; Li J; Tan Y; Zhang M; Bi X; Zhou L; Ci W; Li X
    EBioMedicine; 2023 Mar; 89():104437. PubMed ID: 36758479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reclassification of urinary cytology regarding The Paris System for Reporting Urinary Cytology with cytohistological correlation demonstrates high sensitivity for high-grade urothelial carcinoma.
    Anbardar MH; Monjazeb R
    Diagn Cytopathol; 2020 May; 48(5):446-452. PubMed ID: 31976626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermediate-risk urothelial carcinoma: an unresolved problem?
    Pycha A; Lodde M; Comploj E; Negri G; Egarter-Vigl E; Vittadello F; Lusuardi L; Palermo S; Mian C
    Urology; 2004 Mar; 63(3):472-5. PubMed ID: 15028440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance Characteristics of a Multigene Urine Biomarker Test for Monitoring for Recurrent Urothelial Carcinoma in a Multicenter Study.
    Kavalieris L; O'Sullivan P; Frampton C; Guilford P; Darling D; Jacobson E; Suttie J; Raman JD; Shariat SF; Lotan Y
    J Urol; 2017 Jun; 197(6):1419-1426. PubMed ID: 27986532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Review of Urine Ancillary Tests in the Era of the Paris System.
    Allison DB; VandenBussche CJ
    Acta Cytol; 2020; 64(1-2):182-192. PubMed ID: 31060038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of survivin mRNA in urine of patients with superficial urothelial cell carcinomas.
    Pina-Cabral L; Santos L; Mesquita B; Amaro T; Magalhães S; Criado B
    Clin Transl Oncol; 2007 Nov; 9(11):731-6. PubMed ID: 18055328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Urothelial Bladder Carcinoma via Microfluidic Immunoassay and Single-Cell DNA Copy-Number Alteration Analysis of Captured Urinary-Exfoliated Tumor Cells.
    Chen A; Fu G; Xu Z; Sun Y; Chen X; Cheng KS; Neoh KH; Tang Z; Chen S; Liu M; Huang T; Dai Y; Wang Q; Jin J; Jin B; Han RPS
    Cancer Res; 2018 Jul; 78(14):4073-4085. PubMed ID: 29789419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of urinary bladder cancer with flow cytometry and hexaminolevulinate in urine samples.
    Cunderlíková B; Wahlqvist R; Berner A; Vasovic V; Warloe T; Nesland JM; Peng Q
    Cytopathology; 2007 Apr; 18(2):87-95. PubMed ID: 17397493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical comparison of noninvasive urine tests for ruling out recurrent urothelial carcinoma.
    Lotan Y; OʼSullivan P; Raman JD; Shariat SF; Kavalieris L; Frampton C; Guilford P; Luxmanan C; Suttie J; Crist H; Scherr D; Asroff S; Goldfischer E; Thill J; Darling D
    Urol Oncol; 2017 Aug; 35(8):531.e15-531.e22. PubMed ID: 28366272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.